Patrick Johnson

I began my career in bulk manufacturing for big pharma, and I thought I understood the scale of impact our industry could make. It wasn’t until I entered the world of cell therapy that I found my deeper calling, focusing on those living with CKD. My work has centered on guiding a transformative therapy from early exploration to late stage clinical promise, while also building global pathways to deliver autologous treatments to the patients who need them most. The innovation sparks possibility – its true value lies in the hope it delivers.